Login
$DRMA
$0.87 +$0.12 (15.85%) Close

$DRMA SEC Filings

Filed On Filing
21 Oct 2026 424B3
20 Oct 2026 EFFECT
09 Oct 2026 S-3
18 Aug 2026 Form 4: Proehl Gerald T, Director

Received 170,068 shares as a grant or award · Granted 1,530,612 Series E Warrant (Right to Buy) · Granted 1,530,612 Series F Warrant (Right to Buy) · 1 more

18 Aug 2026 Form 4: Van Hoose Kyri K., SVP, CFO

Received 102,040 shares as a grant or award · Granted 102,040 Series E Warrant (Right to Buy) · Granted 102,040 Series F Warrant (Right to Buy)

17 Aug 2026 25-NSE
17 Aug 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
11 Aug 2026 10-Q
11 Aug 2026 8-K: Results of Operations and Financial Condition
05 Aug 2026 8-K: Other Events
16 Jun 2026 Form 4: Scott Kathleen D., Director

Sold 11 shares ($13.1)

04 Jun 2026 S-8
01 Jun 2026 SCHEDULE 13D
29 May 2026 EFFECT
29 May 2026 424B3
27 May 2026 CORRESP
27 May 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
22 May 2026 S-3/A
13 May 2026 SCHEDULE 13G/A
13 May 2026 10-Q

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support